AstraZeneca defends vaccine distribution plan amid EU supply delays
Article summary
A nurse prepares a does of the Oxford University/AstraZeneca COVID-19 vaccine at the Pontcae Medical Practice in Merthyr Tydfil, Wales, UK. Photo: PA AstraZeneca ( AZN.L ) chief executive Pascal Soriot has defended the firm’s rollout of the COVID-19 vaccine across the EU amid supply delay issues. Soriot said that AstraZeneca were working “24/7 to fix the very many issues of production of the vaccine,” in an interview with Italian newspaper La Repubblica . […] AstraZeneca on Friday (22 January) announced it planned to cut deliveries of the COVID-19 vaccine to the EU by 60% to 31 million doses in the first quarter of the year. […] The NHS is “still under intense pressure” across all parts of the country with 37,899 people in UK hospitals with COVID-19 — including 4,076 on ventilators.
